Long-term Safety and Tolerability of Iptacopan in Patients With Paroxysmal Nocturnal Hemoglobinuria
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Novartis Pharmaceuticals
Related studies linked through entity extraction aliases.
Managed Access Programs for INC424, Ruxolitinib
- Status
- AVAILABLE
- Phase
- N/A
Managed Access Programs for INC280, Capmatinib
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
A Study of the Efficacy and Safety of Secukinumab 300 mg in Patients With Thyroid Eye Disease (TED)
- Status
- TERMINATED
- Phase
- PHASE3
Sacubitril/Valsartan in Heart Failure With Reduced Ejection Fraction Patients: a Real World Study in India
- Status
- COMPLETED
- Phase
- N/A
Efficacy and Safety Study of Secukinumab in Chinese Participants With Non-radiographic Axial Spondyloarthritis
- Status
- COMPLETED
- Phase
- PHASE3
Alpelisib Plus Olaparib in Platinum-resistant/Refractory, High-grade Serous Ovarian Cancer, With no Germline BRCA Mutation Detected
- Status
- TERMINATED
- Phase
- PHASE3
Italian Prospective Observational Study Assessing the Effectiveness and Outcomes Associated With Lutathera Treatment in GEP-NETs
- Status
- COMPLETED
- Phase
- N/A
RadiothErapy priMIng for CAR-T
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Study of Efficacy and Safety of MIJ821 in Addition to Comprehensive Standard of Care on the Rapid Reduction of Symptoms of Major Depressive Disorder in Subjects Who Have Suicidal Ideation With Intent
- Status
- TERMINATED
- Phase
- PHASE2
An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With Standard of Care (SoC), Versus SoC Alone, in Adult Male Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study of Efficacy and Safety of Canakinumab in Japanese Patients With AOSD
- Status
- COMPLETED
- Phase
- PHASE3
Study of [68Ga]-FF58 in Patients With Selected Solid Tumors Expected to Overexpress αvβ3 and αvβ5 Integrins.
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Study of Efficacy and Safety of Secukinumab in Chinese Subjects With Active PsA Compared to Placebo.
- Status
- COMPLETED
- Phase
- PHASE3
VOB560-MIK665 Combination First in Human Trial in Patients With Hematological Malignancies (Relapsed/Refractory Non-Hodgkin Lymphoma, Relapsed/Refractory Acute Myeloid Leukemia, or Relapsed/Refractory Multiple Myeloma)
- Status
- TERMINATED
- Phase
- PHASE1
Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Efficacy and Safety of Brolucizumab 6mg in a Treat and Extend Regimen in Patients With Neovascular Age-Related Macular Degeneration (nAMD) With Prior Anti-VEGF Exposure (PEREGRINE)
- Status
- WITHDRAWN
- Phase
- PHASE3
177Lu-PSMA-617 vs. Androgen Receptor-Directed Therapy in the Treatment of Progressive Metastatic Castrate Resistant Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Efficacy and Safety of Two Different Brolucizumab 6 mg Dosing Regimens in Neovascular Age-related Macular Degeneration
- Status
- COMPLETED
- Phase
- PHASE4
Study of Capmatinib in Chinese Adult Patients With Advanced Non-small Cell Lung Cancer Harboring MET Exon 14 Skipping Mutation
- Status
- COMPLETED
- Phase
- PHASE2